embelin has been researched along with Sepsis in 2 studies
embelin: from Embelia fruit (Myrsinaceae)
embelin : A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease.
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, anticoagulants only reduce the thrombus formation but have negligible effects on the inflammatory conditions." | 5.56 | Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis. ( Andreasen, PA; Chen, Z; Hong, W; Huang, M; Proulle, V; Wang, D; Wang, Y; Xu, P; Yang, Y, 2020) |
| "Embelin has been reported to suppress cytokine expressions in inflammatory disorders." | 5.42 | Embelin Reduces Systemic Inflammation and Ameliorates Organ Injuries in Septic Rats Through Downregulating STAT3 and NF-κB Pathways. ( Cao, J; Huang, L; Zhou, XL, 2015) |
| "However, anticoagulants only reduce the thrombus formation but have negligible effects on the inflammatory conditions." | 1.56 | Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis. ( Andreasen, PA; Chen, Z; Hong, W; Huang, M; Proulle, V; Wang, D; Wang, Y; Xu, P; Yang, Y, 2020) |
| "Embelin has been reported to suppress cytokine expressions in inflammatory disorders." | 1.42 | Embelin Reduces Systemic Inflammation and Ameliorates Organ Injuries in Septic Rats Through Downregulating STAT3 and NF-κB Pathways. ( Cao, J; Huang, L; Zhou, XL, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, D | 1 |
| Yang, Y | 1 |
| Wang, Y | 1 |
| Proulle, V | 1 |
| Andreasen, PA | 1 |
| Hong, W | 1 |
| Chen, Z | 1 |
| Huang, M | 1 |
| Xu, P | 1 |
| Zhou, XL | 1 |
| Huang, L | 1 |
| Cao, J | 1 |
2 other studies available for embelin and Sepsis
| Article | Year |
|---|---|
Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoquinones; Blood Coagulation; Blood Platelets; | 2020 |
Embelin Reduces Systemic Inflammation and Ameliorates Organ Injuries in Septic Rats Through Downregulating STAT3 and NF-κB Pathways.
Topics: Animals; Benzoquinones; Dose-Response Relationship, Drug; Down-Regulation; Inflammation; Male; Multi | 2015 |